,,iii #aai? ,,congress #a/ ,session ,s4 ,,res4 #bcb ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,may #ae1 #bjbe,mr4 ,da9es 7= himself & ,mr4 ,m>key7 submitt$ ! foll[+ resolution2 :i* 0 consid]$ & agre$ to ,,resolution ,designat+ ,may #bjbe z ,national ,bra9 ,tumor ,aw>5ess ,mon?4 ,:]eas x is e/imat$ t m ?an #ic1jjj individuals 9 ! ,unit$ ,/ates w be diagnos$ ) a prim>y bra9 tumor ea* ye>2 ,:]eas x is e/imat$ t m ?an #a1jjj1jjj individuals are liv+ ) a bra9 tumor 9 ! ,unit$ ,/ates2 ,:]eas1 9 ! ,unit$ ,/ates1 bra9 tumors are-- 7#a7 ! lead+ cause ( dea? f canc] 9 *ildr5 :o are "u #ad ye>s ( age & te5s :o are "u #ai ye>s ( age2 & 7#b7 ! second-lead+ cause ( dea? f canc] 9 "y adults :o are betwe5 #ae & #ci ye>s ( age2 ,:]eas ! av]age #e-ye> survival rate = an individual 9 ! ,unit$ ,/ates foll[+ ! diagnosis ( a prim>y malignant bra9 tumor is only #ce4g p]c5t2 ,:]eas x is e/imat$ t #ah1ccj individuals 9 ! ,unit$ ,/ates w die z a result ( a malignant bra9 tumor 9 #bjbe2 ,:]eas bra9 tumors may be malignant or b5ign b c be life-?reat5+ 9 ei!r case2 ,:]eas treatm5t ( bra9 tumors is complicat$ by ! fact t m ?an #ajj types ( bra9 tumors exi/2 ,:]eas ! treatm5t & removal ( bra9 tumors pres5t significant *all5ges due to ! uniquely complex & fragile nature ( ! bra92 ,:]eas bra9 tumors affect ! prim>y organ 9 ! human body t controls n only cognitive ability1 b ! actions ( e o!r organ & limb 9 ! body1 lead+ to bra9 tumors be+ describ$ z a disease t affects ! :ole individual2 ,:]eas bra9 tumor rese>* is support$ by sev]al private1 nonpr(it rese>* f\ndations & by ,f$]al m$ical rese>* in/itutions2 ,:]eas basic rese>* may fuel advancem5ts & ! developm5t ( new treatm5ts = bra9 tumors2 ,:]eas ob/acles to ! developm5t ( new treatm5ts = bra9 tumors rema91 & !re are limit$ /rategies = ! scre5+ or e>ly detection ( bra9 tumors2 ,:]eas1 despite ! high numb] ( individuals diagnos$ ) a bra9 tumor e ye> & ! deva/at+ prognosis = ^? individuals1 only a few treatm5ts h be5 approv$ = malignant bra9 tumors s9ce ! #aihjs2 ,:]eas none ( ! treatm5ts = malignant bra9 tumors ext5d survival by m ?an #b ye>s on av]age or are consid]$ to be curative2 ,:]eas ! mortality rates associat$ ) bra9 tumors h *ang$ little dur+ ! #cj ye>s prec$+ ! date ( introduction ( ?is resolution2 ,:]eas !re is a ne$ = great] public aw>5ess ( bra9 tumors1 includ+ ! difficulties associat$ ) rese>* on bra9 tumors & ! opportunities = advances 9 bra9 tumor rese>* & treatm5t2 & ,:]eas ,may #bjbe1 dur+ :i* bra9 tumor advocates nationwide unite 9 aw>5ess1 outrea*1 & advocacy activities1 is an appropriate mon? to recognize z ,national ,bra9 ,tumor ,aw>5ess ,mon?3 ,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7 designates ,may #bjbe z ,national ,bra9 ,tumor ,aw>5ess ,mon?2 7#b7 enc\rages increas$ public aw>5ess ( bra9 tumors to honor ! individuals :o h lo/ _! lives to a bra9 tumor or curr5tly live ) a bra9 tumor diagnosis2 7#c7 supports ef=ts to develop bett] treatm5ts = bra9 tumors t w improve ! quality ( life & ! long-t]m prognosis ( individuals diagnos$ ) a bra9 tumor2 7#d7 expresses its support = individuals :o are battl+ bra9 tumors1 z well z ! families1 fri5ds1 & c>egiv]s ( ^? individuals2 & 7#e7 urges a collaborative approa* to bra9 tumor rese>*1 :i* is a promis+ means ( advanc+ und]/&+ (1 & treatm5t =1 bra9 tumors4